Cargando…
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
BACKGROUND: Regional citrate or heparin is often prescribed as an anticoagulant for continuous renal replacement therapy (CRRT). However, their efficacy and safety remain controversial. Therefore, we performed this meta-analysis to compare these two agents and to determine whether the currently avai...
Autores principales: | Liu, Chao, Mao, Zhi, Kang, Hongjun, Hu, Jie, Zhou, Feihu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866420/ https://www.ncbi.nlm.nih.gov/pubmed/27176622 http://dx.doi.org/10.1186/s13054-016-1299-0 |
Ejemplares similares
-
Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011) -
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017) -
Citrate Anticoagulation for Continuous Renal Replacement Therapy
in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011) -
Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011) -
Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis
por: Li, Xiaoming, et al.
Publicado: (2021)